Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

Since a schizophrenia drug, the first in decades with an innovative mechanism of action, gained US regulatory approval in ...

EXCLUSIVE: UCL researchers argue that loss of brain volume may in fact be a sign that the treatments are working.

There's no cure for this disease, but now there is some hope for people and their families who are battling the illness in ...

Nov. 21—John Haldi had early-stage Alzheimer's disease when he began a local Aduhelm drug study in June 2020. For three years ...

Lewy body disease (LBD), which includes dementia with Lewy bodies (DLB) and Parkinson’s disease with or without dementia, is ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Long-term use of cardiovascular drugs may reduce dementia risk in older adults by up to 25%, while antiplatelet drugs could ...

Alzheimer’s disease robs patients of so much more than their health. It can rewire their personalities and undermine a ...

Doctors say that once Alzheimer’s takes over the brain there’s little they can do to stop it, but if you catch it early there ...